Abstract
Tramadol is an atypical opioid with a low potential for abuse and dependence. Although studies have pointed to the beneficial effect of adjuvant therapy with tramadol in post-traumatic and obsessive-compulsive stress disorders, no clinical research has been performed so far in patients with major depressive disorder (MDD). Aim: To evaluate the effectiveness of tramadol (daily dose of 150 …